New asthma shot aims to match leading treatment
NCT ID NCT07302516
Summary
This study is testing if a new asthma medicine called QL2302 works as well and is as safe as an existing medicine, Tezspire. It's for adults whose severe asthma is not well controlled by their current inhalers. Participants will receive a shot every four weeks for a year to see which medicine better reduces asthma attacks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.